These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 10923465

  • 21. Effect of oxLDL on the uptake and clearance rate of cholesterol in v-SMC originated from human apoA1 transgenic mice.
    Zeng Y, Zhao G, Qian J, Wang Z, She M.
    Chin Med J (Engl); 2002 Apr; 115(4):584-8. PubMed ID: 12133304
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM.
    Nature; 1991 Sep 19; 353(6341):265-7. PubMed ID: 1910153
    [Abstract] [Full Text] [Related]

  • 23. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.
    Circ Res; 2004 Oct 15; 95(8):789-97. PubMed ID: 15388641
    [Abstract] [Full Text] [Related]

  • 24. [Over-expression in Escherichia coli and characterization of apolipoprotein AI].
    Ding MS, Ma WF, Zhang MF, Liu DT, Guo MJ, Zhuang YP, Chu J, Zhang SL, Gong BQ.
    Sheng Wu Gong Cheng Xue Bao; 2005 Mar 15; 21(2):198-203. PubMed ID: 16013475
    [Abstract] [Full Text] [Related]

  • 25. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
    van der Hoorn JW, de Haan W, Berbée JF, Havekes LM, Jukema JW, Rensen PC, Princen HM.
    Arterioscler Thromb Vasc Biol; 2008 Nov 15; 28(11):2016-22. PubMed ID: 18669886
    [Abstract] [Full Text] [Related]

  • 26. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice.
    Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, Fazio S.
    Arterioscler Thromb Vasc Biol; 2001 Nov 15; 21(11):1790-5. PubMed ID: 11701467
    [Abstract] [Full Text] [Related]

  • 27. Apolipoprotein AI expression and high density lipoprotein distribution in transgenic mice during development.
    Golder-Novoselsky E, Forte TM, Nichols AV, Rubin EM.
    J Biol Chem; 1992 Oct 15; 267(29):20787-90. PubMed ID: 1383210
    [Abstract] [Full Text] [Related]

  • 28. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
    Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I.
    Clin Nutr; 2004 Jun 15; 23(3):401-7. PubMed ID: 15158304
    [Abstract] [Full Text] [Related]

  • 29. Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.
    Recalde D, Baroukh N, Viglietta C, Prince S, Verona J, Vergnes L, Pidoux J, Nazeem Nanjee M, Brites F, Ochoa A, Castro G, Zakin MM, Miller NE, Marie Houdebine L.
    FEBS Lett; 2004 Aug 13; 572(1-3):294-8. PubMed ID: 15304365
    [Abstract] [Full Text] [Related]

  • 30. Coexpression of CLA-1 and human PDZK1 in murine liver modulates HDL cholesterol metabolism.
    Komori H, Arai H, Kashima T, Huby T, Kita T, Ueda Y.
    Arterioscler Thromb Vasc Biol; 2008 Jul 13; 28(7):1298-303. PubMed ID: 18403724
    [Abstract] [Full Text] [Related]

  • 31. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
    Rubin EM, Ishida BY, Clift SM, Krauss RM.
    Proc Natl Acad Sci U S A; 1991 Jan 15; 88(2):434-8. PubMed ID: 1703299
    [Abstract] [Full Text] [Related]

  • 32. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E, Graham MJ, Mullick AE, Miller ER, Crooke RM, Pitas RE, Witztum JL, Tsimikas S.
    Circulation; 2008 Aug 12; 118(7):743-53. PubMed ID: 18663084
    [Abstract] [Full Text] [Related]

  • 33. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y, Yan B, Fu M, Xu Y, Tian Y.
    Clin Chim Acta; 2005 Apr 12; 354(1-2):49-58. PubMed ID: 15748599
    [Abstract] [Full Text] [Related]

  • 34. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.
    Han Y, Qi R, Liu G.
    Biochem Biophys Res Commun; 2015 Jul 10; 462(4):420-5. PubMed ID: 25969427
    [Abstract] [Full Text] [Related]

  • 35. [Effect of conjugated estrogen and Org OD14 on serum lipoprotein and apolipoprotein in perimenopausal and postmenopausal women].
    Bai W, Yang X, Zheng S.
    Zhonghua Fu Chan Ke Za Zhi; 1999 May 10; 34(5):293-6. PubMed ID: 11326938
    [Abstract] [Full Text] [Related]

  • 36. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
    Bach-Ngohou K, Ouguerram K, Frénais R, Maugère P, Ripolles-Piquer B, Zaïr Y, Krempf M, Bard JM.
    J Pharmacol Exp Ther; 2005 Oct 10; 315(1):363-9. PubMed ID: 16014756
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporin A inhibits apolipoprotein AI gene expression.
    Zheng XL, Wong NC.
    J Mol Endocrinol; 2006 Oct 10; 37(2):367-73. PubMed ID: 17032751
    [Abstract] [Full Text] [Related]

  • 38. Colocalization of apolipoprotein AI in various kinds of systemic amyloidosis.
    Sakata N, Hoshii Y, Nakamura T, Kiyama M, Arai H, Omoto M, Morimatsu M, Ishihara T.
    J Histochem Cytochem; 2005 Feb 10; 53(2):237-42. PubMed ID: 15684336
    [Abstract] [Full Text] [Related]

  • 39. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
    Pászty C, Maeda N, Verstuyft J, Rubin EM.
    J Clin Invest; 1994 Aug 10; 94(2):899-903. PubMed ID: 8040345
    [Abstract] [Full Text] [Related]

  • 40. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells.
    Norata GD, Marchesi P, Pirillo A, Uboldi P, Chiesa G, Maina V, Garlanda C, Mantovani A, Catapano AL.
    Arterioscler Thromb Vasc Biol; 2008 May 10; 28(5):925-31. PubMed ID: 18218986
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.